Phase 1 Systemic Lupus Erthematosus trials recruiting now

All Systemic Lupus Erthematosus trials, every phase

Other phases for Systemic Lupus Erthematosus

Phase 1 Systemic Lupus Erthematosus trials

• A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
  NCT07564596 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• A Study of GR1803 in Systemic Lupus Erythematosus
  NCT07348055 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
  NCT06828042 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus
  NCT07136389 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
  NCT06737380 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.